Beranda › Kelebihan Berat Badan › California › San Diego
Uji klinis Kelebihan Berat Badan di San Diego, CA
13 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar San Diego (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Menerima pesertaFase 3
- Artemis Insitute for Clin Res, San Diego
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Menerima pesertaFase 3
- Artemis Institute for Clinical Research, San Diego
- Scripps Whittier Diabetes Institute, La Jolla · 11 mi jauhnya
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Menerima pesertaFase 3
- Acclaim Clinical Research, San Diego
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Menerima pesertaFase 3
- Artemis Institute for Clinical Research, LLC, San Diego
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Menerima pesertaFase 3
- Artemis Insitute for Clin Res, San Diego
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Menerima pesertaFase 3Sukarelawan sehat diterima
- ACCOMPLISH-2 Research Site, San Diego
- ACCOMPLISH-2 Research Site, La Jolla · 11 mi jauhnya
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Menerima pesertaFase 3
- Apex Clinical Research, San Diego
- Artemis Institute for Clinical Research, San Diego
Effects of Watermelon or Low-fat Cookie Consumption on Wellness
Menerima pesertaSukarelawan sehat diterima
- School of Exercise and Nutritional Sciences, San Diego
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Menerima pesertaFase 3
- Apex Clinical Research, San Diego
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Menerima pesertaFase 3
- ACCOMPLISH-1 Research Site, San Diego
- ACCOMPLISH-1 Research Site, La Jolla · 11 mi jauhnya
Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer
Menerima peserta
- University of California San Diego, La Jolla · 11 mi jauhnya
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
Menerima peserta
- University of California San Diego Altman Clinical and Translational Research Institute, La Jolla · 11 mi jauhnya
Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
Menerima pesertaSukarelawan sehat diterima
- San Diego State University, San Diego
Uji klinis Kelebihan Berat Badan di kota lain
- San Antonio, TX34 studi
- Houston, TX33 studi
- Chicago, IL28 studi
- Orlando, FL27 studi
- Las Vegas, NV23 studi
- Miami, FL23 studi
- Atlanta, GA20 studi
- Dallas, TX20 studi
- New York City, NY19 studi
- Jacksonville, FL19 studi
- Washington, DC19 studi
- Austin, TX18 studi
Studi lain di San Diego
- Kanker Paru Non-Sel Kecil48 studi
- Kanker Payudara41 studi
- Kanker (semua jenis)32 studi
- Kanker Prostat31 studi
- Kanker Metastatik30 studi
- Kanker Kolorektal25 studi
- Kanker Pankreas24 studi
- Kanker Ovarium24 studi
- Kanker Paru23 studi
- Gagal Jantung23 studi
- Obesitas23 studi
- Depresi21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.